Top Sell
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
---|---|---|---|---|---|---|---|
Organovo Holdings Inc. | 0 | 7 | 0 | 2 | €0.94 | - | - |
Minerva Neurosciences Inc. | 0 | 5 | 0 | 2 | €2.62 | - | - |
Alterity Therapeutics Ltd. ADR | 0 | 1 | 0 | 0 | €1.32 | - | - |
Formycon AG | 3 | 1 | 0 | 0 | €45.95 | €100.00 | 117.628% |
Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €1.44 | €1.20 | -16.667% |
NanoCarrier Co Ltd | 0 | 1 | 0 | 0 | €0.72 | - | - |
Cardiff Oncology Inc. | 2 | 4 | 0 | 0 | €2.94 | €5.00 | 70.068% |
Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |
AEterna Zentaris Inc. | 3 | 19 | 0 | 1 | €1.87 | €14.02 | 649.759% |
Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.62 | €3.00 | 85.242% |
Shin Nippon Biomedical Laboratories Ltd. | 0 | 1 | 0 | 0 | €7.80 | - | - |
NanoVibronix Inc. | 0 | 1 | 0 | 0 | €0.71 | - | - |
Trevena Inc. | 2 | 15 | 1 | 1 | €0.34 | €6.48 | 1803.671% |
Sage Therapeutics Inc. | 5 | 4 | 0 | 1 | €10.61 | €26.46 | 149.387% |
BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.68 | - | - |
Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.88 | €8.82 | 897.252% |
Carl Zeiss Meditec AG | 2 | 1 | 0 | 0 | €83.35 | €101.00 | 21.176% |
Evotec SE | 4 | 1 | 1 | 0 | €8.93 | €21.50 | 140.896% |
Biofrontera AG | 0 | 2 | 0 | 0 | €0.33 | €0.000 | -100.000% |
Ionis Pharmaceuticals Inc. | 21 | 5 | 4 | 0 | €35.56 | €56.72 | 59.510% |
T2 Biosystems Inc. | 0 | 9 | 0 | 0 | €0.16 | - | - |
Immuron | 0 | 1 | 0 | 0 | €2.02 | - | - |
Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.24 | - | - |
Medigene AG | 1 | 2 | 1 | 0 | €1.22 | €1.00 | -18.033% |
Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €11.10 | €22.00 | 98.198% |